Michael Joner MD

Michael Joner is a Professor for Early Clinical Trials at the German Heart Centre Munich. His main research focus is on findings of novel diagnostic or therapeutic pathways to target atherosclerosis. Dr. Michael Joner MD completed his medical training at the University of Wuerzburg and spent 2004-2006 as a cardiovascular pathology fellow at the CVPath Institute. Prof. Joner’s research wants to find new solutions to identify and treat patients at risk for acute cardiovascular events utilizing innovative diagnostic and therapeutic approaches. His group investigates high-risk markers of atherosclerosis derived from human tissue, which is expected to ultimately feed into molecular imaging approaches to specifically detect and treat high-risk atherosclerotic plaques prone to causing cardiovascular events. Prof. Joner utilizes human-relevant animal models to investigate novel imaging catheters and percutaneous interventional procedures and aims to facilitate early clinical trial investigation of these novel approaches. In a separate aim, his group focuses on optimizing procedures for structural heart interventions in a highly translational setting. 

Prof. Joner hopes that in the long term, it will be possible to identify patients at risk for cardiovascular events before they become symptomatic with acute myocardial infarction or sudden cardiac death. Furthermore, he aims to find a solution for longer-lasting percutaneous procedures in the field of structural heart interventions.